Skip to main content

Advertisement

SpringerLink
Log in

Quantitation of HDAC1 mRNA Expression in Invasive Carcinoma of the Breast*

  • Report
  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

Summary

Estrogen is well-established as a mitogenic factor implicated in the tumorigenesis and progression of breast cancer via its binding to the estrogen receptor α (ERα). Recent data indicate that chromatin inactivation mediated by histone deacetylation (HDAC) and DNA methylation is a critical component of ERα silencing in human breast cancer cells. The aim of this study was to determine the expression of the HDAC1 gene in malignant human breast tissue and to correlate our observations with available clinical information. In the present study, the level of expression of HDAC1 mRNA was assessed by LightCycler-based quantitative real-time reverse transcriptase (RT)-PCR analysis in 162 cases of invasive carcinoma of the breast. Associations between HDAC1 mRNA expression and different clinicopathological factors were sought. It was found that HDAC1 mRNA was expressed at significantly higher levels in tumors from patients over 50 years of age and in those tumors without axillary lymph node involvement, that are less than 2 cm, that are of a non-high histological grade, that are HER2 negative and that are ERα/PgR positive. Patients with tumors displaying high levels of HDAC1 mRNA expression tended to have a better prognosis in terms of both disease-free and overall survival. However, univariate and multivariate analysis did not show HDAC1 mRNA expression level to be an independent prognostic factor for either disease-free or overall survival. These results imply that HDAC1 mRNA expression could have potential as an endocrine response marker and may have prognostic implications for breast cancer progression.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. CK Osborne (1998) ArticleTitleSteroid hormone receptors in breast cancer management Breast Cancer Res Treat 51 227–238 Occurrence Handle10.1023/A:1006132427948 Occurrence Handle10068081 Occurrence Handle1:STN:280:DyaK1M7msFCmsg%3D%3D

    Article  PubMed  CAS  Google Scholar 

  2. GN Hortobagyi (1998) ArticleTitleTreatment of breast cancer N Engl J Med 339 974–984 Occurrence Handle10.1056/NEJM199810013391407 Occurrence Handle9753714 Occurrence Handle1:CAS:528:DyaK1cXmslCitrY%3D

    Article  PubMed  CAS  Google Scholar 

  3. RJ Weigel EC deConinck (1993) ArticleTitleTranscriptional control of estrogen receptor in estrogen receptor-negative breast carcinoma Cancer Res 53 3472–3474 Occurrence Handle8339250 Occurrence Handle1:STN:280:DyaK3szjvVKmsA%3D%3D

    PubMed  CAS  Google Scholar 

  4. EE Cameron KE Bachman S Myohanen JG Herman SB Baylin (1999) ArticleTitleSynergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer Nat Genet 21 103–107 Occurrence Handle10.1038/5047 Occurrence Handle9916800 Occurrence Handle1:CAS:528:DyaK1MXltlWjtA%3D%3D

    Article  PubMed  CAS  Google Scholar 

  5. X Yang AT Ferguson SJ Nass DL Phillips KA Butash SM Wang JG Herman NE Davidson (2000) ArticleTitleTranscriptional activation of estrogen receptor alpha in human breast cancer cells by histone deacetylase inhibition Cancer Res 60 6890–6894 Occurrence Handle11156387 Occurrence Handle1:CAS:528:DC%2BD3MXjsVKqug%3D%3D

    PubMed  CAS  Google Scholar 

  6. H Kawai H Li S Avraham S Jiang HK Avraham (2003) ArticleTitleOverexpression of histone deacetylase HDAC1 modulates breast cancer progression by negative regulation of estrogen receptor alpha Int J Cancer 107 353–358 Occurrence Handle10.1002/ijc.11403 Occurrence Handle14506733 Occurrence Handle1:CAS:528:DC%2BD3sXos1Gns78%3D

    Article  PubMed  CAS  Google Scholar 

  7. M Macaluso C Cinti G Russo A Russo A Giordano (2003) ArticleTitlepRb2/p130-E2F4/5-HDAC1-SUV39H1-p300 and pRb2/p130-E2F4/5-HDAC1-SUV39H1-DNMT1 multimolecular complexes mediate the transcription of estrogen receptor-alpha in breast cancer Oncogene 22 3511–3517 Occurrence Handle10.1038/sj.onc.1206578 Occurrence Handle12789259 Occurrence Handle1:CAS:528:DC%2BD3sXktlSjt7s%3D

    Article  PubMed  CAS  Google Scholar 

  8. A Goldhirsch WC Wood HJ Senn JH Glick RD Gelber (1995) ArticleTitleMeeting highlights: international consensus panel on the treatment of primary breast cancer J Natl Cancer Inst 87 1441–1445 Occurrence Handle7674331 Occurrence Handle1:STN:280:DyaK2MvgsVKntg%3D%3D

    PubMed  CAS  Google Scholar 

  9. CW Elston IO Ellis (1991) ArticleTitlePathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up Histopathology 19 403–410 Occurrence Handle1757079 Occurrence Handle1:STN:280:DyaK38%2FpvVSltw%3D%3D

    PubMed  CAS  Google Scholar 

  10. N Harada O Hatano (1998) ArticleTitleInhibitors of aromatase prevent degradation of the enzyme in cultured human tumour cells Br J Cancer 77 567–572 Occurrence Handle9484813 Occurrence Handle1:CAS:528:DyaK1cXksFGqurg%3D

    PubMed  CAS  Google Scholar 

  11. T Toyama H Iwase P Watson H Muzik E Saettler A Magliocco L DiFrancesco P Forsyth I Garkavtsev S Kobayashi K Riabowol (1999) ArticleTitleSuppression of ING1 expression in sporadic breast cancer Oncogene 18 5187–5193 Occurrence Handle10.1038/sj.onc.1202905 Occurrence Handle10498868 Occurrence Handle1:CAS:528:DyaK1MXmsVyhurk%3D

    Article  PubMed  CAS  Google Scholar 

  12. Z Zhang H Yamashita T Toyama Y Omoto H Sugiura Y Hara X Wu S Kobayashi H Iwase (2003) ArticleTitleQuantitative determination, by real-time reverse transcription polymerase chain reaction, of aromatase mRNA in invasive ductal carcinoma of the breast Breast Cancer Res 5 R250–R256 Occurrence Handle10.1186/bcr657 Occurrence Handle14580261 Occurrence Handle1:CAS:528:DC%2BD3sXptFOntbw%3D

    Article  PubMed  CAS  Google Scholar 

  13. I Bieche I Laurendeau S Tozlu M Olivi D Vidaud R Lidereau M Vidaud (1999) ArticleTitleQuantitation of MYC gene expression in sporadic breast tumors with a real-time reverse transcription-PCR assay Cancer Res 59 2759–2765 Occurrence Handle10383126 Occurrence Handle1:CAS:528:DyaK1MXktVOktbo%3D

    PubMed  CAS  Google Scholar 

  14. S Kobayashi Y Ito Y Ando Y Omoto T Toyama H Iwase (2000) ArticleTitleComparison of five different antibodies in the immunohistochemical assay of estrogen receptor alpha in human breast cancer Breast Cancer 7 136–141 Occurrence Handle11029785 Occurrence Handle1:STN:280:DC%2BD3MzgsFelsg%3D%3D Occurrence Handle10.1007/BF02967445

    Article  PubMed  CAS  Google Scholar 

  15. Z Zhang H Yamashita T Toyama Y Hara Y Omoto H Sugiura S Kobayashi N Harada H Iwase (2002) ArticleTitleSemi-quantitative immunohistochemical analysis of aromatase expression in ductal carcinoma in situ of the breast Breast Cancer Res Treat 74 47–53 Occurrence Handle10.1023/A:1016022314608 Occurrence Handle12150452 Occurrence Handle1:CAS:528:DC%2BD38XkslKltL8%3D

    Article  PubMed  CAS  Google Scholar 

  16. JM Harvey GM Clark CK Osborne DC Allred (1999) ArticleTitleEstrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer J Clin Oncol 17 1474–1481 Occurrence Handle10334533 Occurrence Handle1:STN:280:DyaK1M3msFOjsA%3D%3D

    PubMed  CAS  Google Scholar 

  17. H Yamashita M Nishio T Toyama H Sugiura Z Zhang S Kobayashi H Iwase (2004) ArticleTitleCoexistence of HER2 over-expression and p53 protein accumulation is a strong prognostic molecular marker in breast cancer Breast Cancer Res 6 R24–R30 Occurrence Handle10.1186/bcr738 Occurrence Handle14680497 Occurrence Handle1:CAS:528:DC%2BD2cXnsl2hsQ%3D%3D

    Article  PubMed  CAS  Google Scholar 

  18. AP Wolffe (2001) ArticleTitleChromatin remodeling: why it is important in cancer Oncogene 20 2988–2990 Occurrence Handle10.1038/sj.onc.1204322 Occurrence Handle11420713 Occurrence Handle1:CAS:528:DC%2BD3MXks1Gltbs%3D

    Article  PubMed  CAS  Google Scholar 

  19. S Thiagalingam KH Cheng HJ Lee N Mineva A Thiagalingam JF Ponte (2003) ArticleTitleHistone deacetylases: unique players in shaping the epigenetic histone code Ann NY Acad Sci 983 84–100 Occurrence Handle12724214 Occurrence Handle1:CAS:528:DC%2BD3sXjt1yrs7g%3D Occurrence Handle10.1111/j.1749-6632.2003.tb05964.x

    Article  PubMed  CAS  Google Scholar 

  20. P Loidl (1988) ArticleTitleTowards an understanding of the biological function of histone acetylation FEBS Lett 227 91–95 Occurrence Handle10.1016/0014-5793(88)80874-3 Occurrence Handle3338575 Occurrence Handle1:CAS:528:DyaL1cXht1Krtr4%3D

    Article  PubMed  CAS  Google Scholar 

  21. SY Roth JM Denu CD Allis (2001) ArticleTitleHistone acetyltransferases Annu Rev Biochem 70 81–120 Occurrence Handle10.1146/annurev.biochem.70.1.81 Occurrence Handle11395403 Occurrence Handle1:CAS:528:DC%2BD3MXlsVehtrc%3D

    Article  PubMed  CAS  Google Scholar 

  22. M Vidal RF Gaber (1991) ArticleTitleRPD3 encodes a second factor required to achieve maximum positive and negative transcriptional states in Saccharomyces cerevisiae Mol Cell Biol 11 6317–6327 Occurrence Handle1944291 Occurrence Handle1:CAS:528:DyaK38XmsVKmsr8%3D

    PubMed  CAS  Google Scholar 

  23. J Taunton CA Hassig SL Schreiber (1996) ArticleTitleA mammalian histone deacetylase related to the yeast transcriptional regulator Rpd3p Science 272 408–411 Occurrence Handle8602529 Occurrence Handle1:CAS:528:DyaK28XisVegsr8%3D

    PubMed  CAS  Google Scholar 

  24. HH Ng A Bird (2000) ArticleTitleHistone deacetylases: silencers for hire Trends Biochem Sci 25 121–126 Occurrence Handle10.1016/S0968-0004(00)01551-6 Occurrence Handle10694882 Occurrence Handle1:STN:280:DC%2BD3c7nsFOruw%3D%3D

    Article  PubMed  CAS  Google Scholar 

  25. J Ahringer (2000) ArticleTitleNuRD and SIN3 histone deacetylase complexes in development Trends Genet 16 351–356 Occurrence Handle10.1016/S0168-9525(00)02066-7 Occurrence Handle10904264 Occurrence Handle1:CAS:528:DC%2BD3cXlsVOqt7o%3D

    Article  PubMed  CAS  Google Scholar 

  26. KB Glaser J Li MJ Staver RQ Wei DH Albert SK Davidsen (2003) ArticleTitleRole of class I and class II histone deacetylases in carcinoma cells using siRNA Biochem Biophys Res Commun 310 529–536 Occurrence Handle10.1016/j.bbrc.2003.09.043 Occurrence Handle14521942 Occurrence Handle1:CAS:528:DC%2BD3sXns1Krs7o%3D

    Article  PubMed  CAS  Google Scholar 

  27. P Marks RA Rifkind VM Richon R Breslow T Miller WK Kelly (2001) ArticleTitleHistone deacetylases and cancer: causes and therapies Nat Rev Cancer 1 194–202 Occurrence Handle10.1038/35106079 Occurrence Handle11902574 Occurrence Handle1:CAS:528:DC%2BD38XlvF2qtr0%3D

    Article  PubMed  CAS  Google Scholar 

  28. JH Choi HJ Kwon BI Yoon JH Kim SU Han HJ Joo DY Kim (2001) ArticleTitleExpression profile of histone deacetylase 1 in gastric cancer tissues Jpn J Cancer Res 92 1300–1304 Occurrence Handle11749695 Occurrence Handle1:CAS:528:DC%2BD38XhtV2jt7c%3D

    PubMed  CAS  Google Scholar 

  29. JH Kim YK Choi HJ Kwon HK Yang JH Choi DY Kim (2004) ArticleTitleDownregulation of gelsolin and retinoic acid receptor beta expression in gastric cancer tissues through histone deacetylase 1 J Gastroenterol Hepatol 19 218–224 Occurrence Handle10.1111/j.1440-1746.2004.03336.x Occurrence Handle14731134 Occurrence Handle1:CAS:528:DC%2BD2cXitVeitrw%3D

    Article  PubMed  CAS  Google Scholar 

  30. Y Toh M Yamamoto K Endo Y Ikeda H Baba S Kohnoe H Yonemasu Y Hachitanda T Okamura K Sugimachi (2003) ArticleTitleHistone H4 acetylation and histone deacetylase 1 expression in esophageal squamous cell carcinoma Oncol Rep 10 333–338 Occurrence Handle12579268 Occurrence Handle1:CAS:528:DC%2BD3sXhvFGks7g%3D

    PubMed  CAS  Google Scholar 

  31. K Halkidou L Gaughan S Cook HY Leung DE Neal CN Robson (2004) ArticleTitleUpregulation and nuclear recruitment of HDAC1 in hormone refractory prostate cancer Prostate 59 177–189 Occurrence Handle10.1002/pros.20022 Occurrence Handle15042618 Occurrence Handle1:CAS:528:DC%2BD2cXktl2lsLo%3D

    Article  PubMed  CAS  Google Scholar 

  32. H Sasaki S Moriyama Y Nakashima Y Kobayashi M Kiriyama I Fukai Y Yamakawa Y Fujii (2004) ArticleTitleHistone deacetylase 1 mRNA expression in lung cancer Lung Cancer 46 171–178 Occurrence Handle10.1016/j.lungcan.2004.03.021 Occurrence Handle15474665

    Article  PubMed  Google Scholar 

  33. S Khochbin A Verdel C Lemercier D Seigneurin-Berny (2001) ArticleTitleFunctional significance of histone deacetylase diversity Curr Opin Genet Dev 11 162–166 Occurrence Handle10.1016/S0959-437X(00)00174-X Occurrence Handle11250139 Occurrence Handle1:CAS:528:DC%2BD3MXis1akurg%3D

    Article  PubMed  CAS  Google Scholar 

  34. AJ Ruijter Particlede AH Gennip Particlevan HN Caron S Kemp AB Kuilenburg Particlevan (2003) ArticleTitleHistone deacetylases (HDACs): characterization of the classical HDAC family Biochem J 370 737–749 Occurrence Handle10.1042/BJ20021321 Occurrence Handle12429021

    Article  PubMed  Google Scholar 

  35. WJ Meehan RS Samant JE Hopper MJ Carrozza LA Shevde JL Workman KA Eckert MF Verderame DR Welch (2004) ArticleTitleBreast cancer metastasis suppressor 1 (BRMS1) forms complexes with retinoblastoma-binding protein 1 (RBP1) and the mSin3 histone deacetylase complex and represses transcription J Biol Chem 279 1562–1569 Occurrence Handle10.1074/jbc.M307969200 Occurrence Handle14581478 Occurrence Handle1:CAS:528:DC%2BD2cXhtV2hsQ%3D%3D

    Article  PubMed  CAS  Google Scholar 

  36. Sharma D, Blum J, Yang X, Beaulieu N, Macleod AR, Davidson NE: Release of methyl CpG binding proteins and Histone Deacetylase 1 from the estrogen receptor Alpha (ER) Promoter upon reactivation in ER-negative human breast cancer cells. Mol. Endocrinol., Mar 2005, 10.1210/me.2004–0011

Download references

Author information

Authors and Affiliations

  1. Department of Breast and Endocrine Surgery, Medical School, Nagoya City University Hospital, Kawasumi 1, Mizuho-ku, 467-8601, Nagoya, Japan

    Zhenhuan Zhang, Hiroko Yamashita, Tatsuya Toyama, Hiroshi Sugiura, Yoshiaki Ando, Keiko Mita, Maho Hamaguchi, Yasuo Hara & Hirotaka Iwase

  2. Department of Surgery, Josai Municipal Hospital of Nagoya, Kitabata 4-1, akamura-ku, 453-0815, Nagoya, Japan

    Shunzo Kobayashi

Authors
  1. Zhenhuan Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hiroko Yamashita
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Tatsuya Toyama
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Hiroshi Sugiura
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Yoshiaki Ando
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Keiko Mita
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Maho Hamaguchi
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Yasuo Hara
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Shunzo Kobayashi
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Hirotaka Iwase
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hirotaka Iwase.

Additional information

Three potential reviewers:

1. Shin-Ichi Hayashi, Tohoku University e-mail: shayashi@mail.tains.tohoku.ac.jp.

2. Hiroji Iwata, Aichi Cancer Center e-mail: hiwata@aichi-cc.jp.

3. Reiki Nishimura, Kumamoto City Hospital e-mail: j_nishimura2002@yahoo.co.jp.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zhang, Z., Yamashita, H., Toyama, T. et al. Quantitation of HDAC1 mRNA Expression in Invasive Carcinoma of the Breast*. Breast Cancer Res Treat 94, 11–16 (2005). https://doi.org/10.1007/s10549-005-6001-1

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10549-005-6001-1

Key words

Search

Navigation